Crossmark

Reply to the Correspondence Regarding: “Short-Course Potent P2Y12 Inhibitor–Based DAPT Versus Clopidogrel-Based DAPT After PCI: A Propensity-Matched Real-World Study”

Crossref DOI link: https://doi.org/10.1007/s10557-025-07779-x

Published Online: 2025-09-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kulsumritpon, Natchanon https://orcid.org/0009-0004-8616-7625
License Information

Text and Data Mining valid from 2025-09-16

Version of Record valid from 2025-09-16
More Information

Article History

Accepted: 6 September 2025

First Online: 16 September 2025

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below